Lexicon Pharmaceuticals, Inc. (LXRX) Earnings Per Share (EPS)
Lexicon Pharmaceuticals, Inc. (LXRX) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | -$1.36 |
| 2017-12-31 | -$1.23 |
| 2018-12-31 | -$1.14 |
| 2019-12-31 | $1.23 |
| 2020-12-31 | -$0.53 |
| 2021-12-31 | -$0.60 |
| 2022-12-31 | -$0.62 |
| 2023-12-31 | -$0.80 |
| 2024-12-31 | -$0.63 |
| 2025-12-31 | -$0.14 |
How LXRX compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| CERS | Cerus Corporation | -$0.08 |
| HRTX | Heron Therapeutics Inc. | -$0.12 |
| BRKR | Bruker Corporation | -$0.15 |
| ETON | Eton Pharmaceuticals Inc. | -$0.17 |
| DYAI | Dyadic International Inc. | -$0.23 |
These are five companies in the same sector as LXRX with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Lexicon Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("LXRX")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | LXRX | $2.40 | -2.83% | 2.70M |
| 3 | ||||
| 4 | ||||
| 5 |